Evidence map›Paper›PMID 30533582›Full record

ArticleACS omega2018

Indole Alkaloid Derivative B, a Novel Bifunctional Agent That Mitigates 5-Fluorouracil-Induced Cardiotoxicity.

Wei Bi, Yue Bi, Pengfei Li, Shanshan Hou, Xin Yan, Connor Hensley, Catherine E Bammert, Yanrong Zhang, K Michael Gibson, Jingfang Ju and 1 more

Open access · goldAbstract read
In one paragraph

Article in ACS omega, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. A novel class of indole derivatives: enhanced bioavailability, permeability, and antioxidant efficacy for thromboembolic disease therapy.Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents · 2024
    Article
  4. Article
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Wei BiSecond Hospital of HeBei Medical University, Shijiazhuang 050000, P. R. China.
Yue BiSecond Hospital of HeBei Medical University, Shijiazhuang 050000, P. R. China.
Pengfei LiSecond Hospital of HeBei Medical University, Shijiazhuang 050000, P. R. China.
Shanshan HouDepartment of Chemistry and Biological Sciences, Michigan Technological University, Houghton, Michigan 49931, United States.
Xin YanDepartment of Chemistry and Biological Sciences, Michigan Technological University, Houghton, Michigan 49931, United States.
Connor HensleyDepartment of Chemistry and Biological Sciences, Michigan Technological University, Houghton, Michigan 49931, United States.
Catherine E BammertDepartment of Chemistry and Biological Sciences, Michigan Technological University, Houghton, Michigan 49931, United States.
Yanrong ZhangSecond Hospital of HeBei Medical University, Shijiazhuang 050000, P. R. China.
K Michael GibsonDepartment of Pharmacotherapy, College of Pharmacy and Pharmaceutical Sciences, Washington State University, Spokane, Washington 99202, United States.
Jingfang JuTranslational Research Laboratory, Department of Pathology, Stony Brook University, Stony Brook, New York 11794, United States.
Lanrong BiDepartment of Chemistry and Biological Sciences, Michigan Technological University, Houghton, Michigan 49931, United States.
Michigan Technological University · USHebei Medical University · CNStony Brook University · USWashington State University Spokane · US

Funding

Enhancing the "Barcode" Readability of Color-Labeled Molecular Tags by Linker EngR15GM088795 · NIGMS · MICHIGAN TECHNOLOGICAL UNIVERSITY · PI BI, LANRONG · 2009 to 2009
$202k
NIGMS NIH HHS R15 GM088795
6 · The paper itself

Abstract

Clinically approved therapeutics that mitigate chemotherapy-induced cardiotoxicity, a serious adverse effect of chemotherapy, are lacking. The aim of this study was to determine the putative protective capacity of a novel indole alkaloid derivative B (

Identifiers

PMID30533582
PMCPMC6275955
OpenAlexW2900586793

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.